Vaginosis, Bacterial
Recent clinical, regulatory, research and industry developments relating to this disease.
Inflammatory mediators in bacterial vaginosis: The role of cytokines.
The Female Vaginal Microbiome in Health and Bacterial Vaginosis.
Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Microbiota2
- Vaginosis, Bacterial2
- Premature Birth1
- Sexually Transmitted Diseases1
Leading journals3
- APMIS : acta pathologica, microbiologica, et immunologica Scandinavica1
- Frontiers in cellular and infection microbiology1
- Microbial cell factories1
Leading researchers8
- Chee WJY1
- Chen T1
- Chen X1
- Chew SY1
- He Z1
- Li R1
- Lu Y1
- Than LTL1
Affiliations (unnormalised)3
- Center of Clinical Laboratory Medicine1
- Department of Clinical Laboratory1
- Universiti Putra Malaysia1
Reference
Authoritative identity, definition & identifiers.
Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.